Intractable pain with breast cancer

Area of Science:

• Oncology
• Pain Management
• Clinical Medicine

Background:

• Breast cancer is a leading cause of cancer-related morbidity.
• Intractable pain significantly impacts patient quality of life and treatment outcomes.
• Understanding pain etiology is crucial for effective management.

Purpose of the Study:

• To retrospectively analyze the causes, clinical features, and treatment outcomes of intractable pain in breast cancer patients.
• To differentiate pain patterns based on origin (skeletal metastases, brachial plexus neuropathy, psychogenic).
• To correlate pain onset with survival in patients with metastatic breast cancer.

Main Methods:

• Retrospective analysis of 210 breast cancer patients with intractable pain.
• Categorization of pain based on clinical presentation and etiology.
• Evaluation of treatment strategies tailored to individual pain profiles.
• Survival analysis based on pain characteristics and metastatic disease.

Main Results:

• Three primary pain types identified: skeletal metastases, brachial plexus neuropathy, and psychogenic pain.
• Psychogenic pain onset correlated with cancer diagnosis; metastatic pain latency averaged 3.7 years.
• Custom-tailored treatments were administered based on patient and pain specifics.
• Intractable pain from metastatic disease predicted a median survival of 9 months.

Conclusions:

• Breast cancer pain has diverse origins, requiring specific diagnostic and therapeutic approaches.
• Early identification of pain etiology, particularly metastatic pain, is critical for prognosis.
• Personalized pain management strategies are essential for improving patient care in advanced breast cancer.